Hepatocellular carcinoma (HCC) is one of the most common malignant tumours worldwide. The major etiologies and risk factors for HCC development are well defined and some of the multiple steps involved in hepatocarcinogenesis have been elucidated in recent years. Despite these scientific advances and ...
Hepatocellular carcinoma (HCC) is a common type of tumor worldwide. The development of systemic treatment of advanced HCC has remained stagnant for a considerable period. During the last years, a series of new treatment regimens based on the combination of immunotherapeutic drugs and targeted drugs ...
Treatment of hepatocellular carcinoma 来自 Semantic Scholar 喜欢 0 阅读量: 39 作者: HE Blum 摘要: Hepatocellular carcinoma (HCC) is one of the most common malignant tumours worldwide. The major etiologies and risk factors for HCC development are well defined and some of the multiple steps ...
Ajit Kumar PadhySpringer Berlin HeidelbergPadhy AK (2013). Rhenium-188 Lipiodol for the Treatment of Hepatocellular Carcinoma (HCC). In: A. Adam, R.F. Dondelingar, P.R. Mueller (Eds.) Interventional Radiology in Cancer, Springer, Berlin...
1 Hepatocellular carcinoma (HCC) is the most common pathological type of PMC, and accounts for more than 80% of cases.2 However, in clinical practice, the outcomes of HCC treatment are unsatisfactory. Since the early stages of HCC do not necessarily manifest typical symptoms, a considerable ...
the liver of patients with hepatocellular carcinoma: possible involvement in the escape from tumor rejection: Satoshi Yamagiwa, Takafumi Ichida, Xiu Hua Yang, Satoshi Sugahara, Toru Ishikawa, Hisami Watanabe, Yoshinobu Sato, Toru Abo, Hitoshi Asakura, Niigata University School of Medicine, Niigata ...
定价:$ 236.17 ISBN:9783642160363 豆瓣评分 目前无人评价 评价: 写笔记 写书评 加入购书单 分享到 内容简介· ··· It is now widely accepted that multidisciplinary collaboration and multimodality treatment approaches are important in improving the survival of patients with hepatocellular carcinoma. In this...
Future treatment strategies for HCC with PVTT in China would depend on new evidences from more future clinical trials, especially studies defining the role of traditional Chinese medicine and clarifying molecular aspects of HCC. 展开 关键词: hepatocellular carcinoma, portal vein tumor thrombosis, ...
The hypoxic microenvironment inside solid tumors, including hepatocellular carcinoma (HCC), is a major cause of tumor resistance to chemotherapy. The recently identified hypoxia-inducible factor (HIF)-2 executes the hypoxia response. Its expression feature and transcriptional targets indicate a possible do...
Hepatocellular carcinoma (HCC) is an aggressive cancer with limited treatment options.1 Natural killer (NK) cells are innate lymphoid cells that play crucial roles in the control of HCC and have tremendous potential as effective immunotherapies in HCC treatment.2, 3 Initially, autologous NK cells ...